Razazi, Keyvan
Martins Bexiga, Anissa
Arrestier, Romain
Peiffer, Bastien
Voiriot, Guillaume
Luyt, Charles-Edouard
Urbina, Tomas
Mayaux, Julien
Pham, Tài
Roux, Damien
Bellaiche, Raphael
AIt Hamou, Zakaria
Gaudry, Stéphane
Azoulay, Elie
Mekontso Dessap, Armand
Rodriguez, Christophe
Pawlotsky, Jean-Michel
Fourati, Slim
de Prost, Nicolas
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-21-COVR-0022)
Article History
Received: 27 September 2022
Accepted: 16 April 2023
First Online: 24 April 2023
Competing interests
: C.-E. L. has served as consultant for Bayer Healthcare, Carmat and Thermo Fisher Brahms, and received lecture fees from MSD, Aerogen, Advanzpharma and BioMérieux, outside the submitted work. J.-M.P. has served as an advisor or speaker for Gilead, Abbvie, Merck, Assembly Biosciences and Arbutus. Other authors have no conflict of interest to disclose.